Promega corporation:1107424 [19-001937]
Ended Purchase Order Awarded
- Contract number
- 75N95019P00184
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $127,908
Award facts
- Opportunity
-
- Promega-brand reagent kits and assays for NCATS Chemical Genomics Center Solicitation · 75N95019Q00095 · Posted Feb 22, 2019
- Contract value 100% obligated
- $127,908.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This is a $127,908.40 firm fixed-price purchase order awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The award is for Promega's proprietary reagent kits and assay products, which are sole source procured due to their specialized capabilities required to support NCATS' ongoing laboratory research and high-throughput screening programs. This award was not set aside for any specific business category. Promega has existing federal contract vehicles in place with NCATS, the Defense Health Agency, and the Federal Bureau of Investigation, allowing for streamlined procurement of its life science products, instrumentation, and services across the government. The products delivered under this purchase order will enable advanced cell-based assays, DNA analysis, and molecular diagnostics integral to NCATS' drug discovery and translational science initiatives.
Quick answers
Who was awarded contract 75N95019P00184?
75N95019P00184 was awarded to Promega Corporation by National Institute on Drug Abuse (National Institutes of Health) on March 5, 2019.
How much is contract 75N95019P00184 worth?
The government has obligated $127,908 on 75N95019P00184.
Which agency awarded contract 75N95019P00184?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019P00184, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95019P00184 competed?
The extent of competition for 75N95019P00184 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award